This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Amicus Therapeutics Inc
FOLD : NASDAQ : Health Care
$6.61 | %
Today's Range: 6.37 - 6.84
Avg. Daily Volume: 2,989,700
09/19/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
FOLD AMICUS THERAPEUTICS INC 6.77 532.81 n/m 1.29 n/a
INO INOVIO PHARMACEUTICALS INC 10.51 634.79 n/m 17.39 310.91
PRTA PROTHENA CORP PLC 21.98 601.72 n/m 47.69 5123.76
OREX OREXIGEN THERAPEUTICS INC 4.88 597.97 n/m 3.43 0.00
MNTA MOMENTA PHARMACEUTICALS INC 11.07 584.64 n/m 45.24 51.82
ONVO ORGANOVO HOLDINGS INC 7.16 561.92 n/m 0.37 -68.56
OMED ONCOMED PHARMACEUTICALS 17.90 532.72 n/m 43.95 113.98
SPPI SPECTRUM PHARMACEUTICALS INC 8.07 530.46 n/m 170.93 -15.98
HPTX HYPERION THERAPEUTICS INC 25.00 514.95 27.78 90.69 1021.32
AMAG AMAG PHARMACEUTICALS INC 22.87 502.18 n/m 88.96 16.42
ARRY ARRAY BIOPHARMA INC 3.75 494.36 n/m 42.08 -39.53
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

FOLD Ind Avg S&P 500
n/m 81.35 19.67
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs